Optimizing Clinical Use of Biologics in Orthopaedic Surgery: Consensus Recommendations From the 2018 AAOS/NIH U-13 Conference

Concern that misinformation from direct-to-consumer marketing of largely unproven “biologic” treatments such as platelet-rich plasma and cell-based therapies may erode the public trust and the responsible investment needed to bring legitimate biological therapies to patients have resulted in calls t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Constance R., Rodeo, Scott, Bhutani, Nidhi, Goodrich, Laurie R., Huard, Johnny, Irrgang, James, LaPrade, Robert F., Lattermann, Christian, Lu, Ying, Mandelbaum, Bert, Mao, Jeremy, McIntyre, Louis, Mishra, Allan, Muschler, George F., Piuzzi, Nicolas S., Potter, Hollis, Spindler, Kurt, Tokish, John M., Tuan, Rocky, Zaslav, Kenneth, Maloney, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314629/
https://www.ncbi.nlm.nih.gov/pubmed/30300216
http://dx.doi.org/10.5435/JAAOS-D-18-00305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314629/
https://www.ncbi.nlm.nih.gov/pubmed/30300216
http://dx.doi.org/10.5435/JAAOS-D-18-00305

Ejemplares similares